Main > INFECTIOUS DISEASES > USA. E. COVID-19>Treat.>SARS-CoV-2>

---

USA. E. COVID-19>Treat.>SARS-CoV-2>'s subsections
(*) CA Approval Date: 2020. 11.20
(*) USA EUA Date: 2020. 11.09
>Spike Protein Receptor Binding Dom
Company
Generic Name: BamlaniviMAb
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 10.26.
PR Web-Site

USA. E. COVID-19>Treat.>SARS-CoV-2>'s products
This section has no products